Biogen Inc (BIIB)

Date: O: H: L: C: Vol:

Biogen Inc Stock (BIIB) Forecast

The Biogen Inc (BIIB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $231.59, representing a -8.69% decrease from the current price of $253.62. The highest analyst price target is $259.53, and the lowest is $203.65.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month BIIB Price Target

Average 210.93 (-16.83% Downside)

Is Biogen Inc (BIIB) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	66.65	Neutral
STOCH(9,6)	77.10	Neutral
STOCHRSI(14)	45.19	Neutral
MACD(12,26)	7.84	Buy
ADX(14)	33.39	Buy
William %R	-16.09	Sell
CCI(14)	69.15	Neutral

Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	247.44 Buy	246.60 Buy
MA20	237.32 Buy	240.23 Buy
MA50	227.08 Buy	229.13 Buy
MA100	215.95 Buy	218.24 Buy
MA200	201.18 Buy	201.59 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, BIIB could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BIIB, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 66.65 indicates that BIIB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 77.10 indicates that BIIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 45.19 indicates that BIIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 33.39 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 69.15 indicates that BIIB is still overbought but not to an extreme extent.

Long-term BIIB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Biogen Inc financial reports and earnings history, Biogen Inc (BIIB) stock could reach $183.80 by 2030, $225.77 by 2040 and $189.02 by 2050. See the projected annual prices until 2050 of the Biogen Inc stock below:

Biogen Inc (BIIB) is expected to reach an average price of $110.46 in 2035, with a high prediction of $204.07 and a low estimate of $106.27. This indicates an -56.45% change from the last recorded price of $253.62.
Biogen Inc (BIIB) stock is projected to chart a bullish course in 2040, with an average price target of $145.74, representing an -42.53% change from its current level. The forecast ranges from a conservative $117.61 to a sky-high $225.77.
Our analysts predict Biogen Inc (BIIB) to change -34.35% by 2045, soaring from $151.65 to an average price of $166.49, potentially reaching $222.45. While $151.65 is the low estimate, the potential upside is significant.
Biogen Inc (BIIB) stock is expected to climb by 2050, reaching an average of $148.03, a -41.63% change from its current level. However, a wide range of estimates exists, with high and low targets of $189.02 and $63.04, respectively, highlighting the market's uncertainty.

Biogen Inc Stock (BIIB) Year by Year Forecast

Biogen Inc Stock (BIIB) Price Forecast for 2026

The predicted value for Biogen Inc (BIIB) in 2026 is set at an average of $206.38. Estimates vary from a peak of $259.53 to a trough of $160.36, indicating an -18.63% surge from the present price of $253.62.

Month	Average	Low	High	Change from today's price
November, 2026	$210.71	$203.65	$259.53	-16.92%
December, 2026	$210.41	$196.70	$218.42	-17.04%

Biogen Inc Stock (BIIB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Biogen Inc (BIIB) is $194.18, with a high forecast of $262.77 and a low forecast of $162.34. This indicates an -23.44% decrease from the last price of $253.62.

Month	Average	Low	High	Change from today's price
January, 2027	$195.55	$192.12	$240.55	-22.90%
February, 2027	$189.65	$187.61	$206.27	-25.22%
March, 2027	$172.77	$170.04	$193.32	-31.88%
April, 2027	$185.78	$167.78	$191.48	-26.75%
May, 2027	$168.78	$165.82	$200.65	-33.45%
June, 2027	$175.20	$162.34	$182.55	-30.92%
July, 2027	$187.16	$163.76	$187.94	-26.20%
August, 2027	$181.52	$175.11	$197.47	-28.43%
September, 2027	$189.39	$179.45	$198.11	-25.33%
October, 2027	$187.17	$168.96	$188.25	-26.20%
November, 2027	$240.00	$169.79	$258.79	-5.37%
December, 2027	$257.22	$235.70	$262.77	+1.42%

Biogen Inc Stock (BIIB) Price Forecast for 2028

In 2028, Biogen Inc (BIIB) is projected to reach an average price of $257.45, with a high projection of $295.43 and a low estimate of $228.42. This indicates an +1.51% rise from the last price of $253.62.

Month	Average	Low	High	Change from today's price
January, 2028	$274.34	$256.50	$287.31	+8.17%
February, 2028	$252.39	$247.67	$275.14	-0.49%
March, 2028	$265.58	$240.79	$271.39	+4.71%
April, 2028	$253.91	$244.78	$268.98	+0.11%
May, 2028	$238.73	$230.36	$253.29	-5.87%
June, 2028	$263.73	$236.52	$266.50	+3.99%
July, 2028	$284.12	$250.51	$295.36	+12.02%
August, 2028	$284.55	$267.28	$286.95	+12.19%
September, 2028	$250.77	$250.45	$295.43	-1.13%
October, 2028	$244.65	$231.85	$258.44	-3.54%
November, 2028	$243.13	$235.50	$254.69	-4.14%
December, 2028	$233.48	$228.42	$246.28	-7.94%

Biogen Inc Stock (BIIB) Price Forecast for 2029

The 2029 price forecast for Biogen Inc Stock (BIIB) is $202.52 on average, with a high prediction of $245.26 and a low estimate of $165.50. This represents an -20.15% decrease from the previous price of $253.62.

Month	Average	Low	High	Change from today's price
January, 2029	$210.35	$209.59	$245.26	-17.06%
February, 2029	$203.86	$196.72	$227.36	-19.62%
March, 2029	$215.18	$199.77	$216.70	-15.15%
April, 2029	$224.05	$218.40	$244.22	-11.66%
May, 2029	$219.68	$215.96	$228.12	-13.38%
June, 2029	$192.98	$191.67	$222.41	-23.91%
July, 2029	$191.66	$187.05	$206.24	-24.43%
August, 2029	$184.96	$165.50	$191.73	-27.07%
September, 2029	$206.66	$184.61	$212.99	-18.51%
October, 2029	$200.13	$186.44	$213.66	-21.09%
November, 2029	$202.56	$196.16	$214.15	-20.13%
December, 2029	$178.11	$173.09	$212.65	-29.77%

Biogen Inc Stock (BIIB) Price Forecast for 2030

Biogen Inc Stock (BIIB) is expected to reach an average price of $125.76 in 2030, with a high forecast of $183.80 and a low forecast of $86.53. This signifies an -50.42% decrease from the last price of $253.62.

Month	Average	Low	High	Change from today's price
January, 2030	$171.86	$168.48	$183.80	-32.24%
February, 2030	$161.94	$159.82	$180.42	-36.15%
March, 2030	$150.29	$150.17	$170.41	-40.74%
April, 2030	$136.96	$129.94	$155.51	-46.00%
May, 2030	$127.67	$121.42	$141.62	-49.66%
June, 2030	$116.94	$116.44	$132.75	-53.89%
July, 2030	$117.07	$104.93	$126.07	-53.84%
August, 2030	$117.36	$114.81	$133.54	-53.73%
September, 2030	$95.11	$86.53	$120.62	-62.50%
October, 2030	$94.70	$91.78	$101.86	-62.66%
November, 2030	$109.69	$95.72	$111.30	-56.75%
December, 2030	$109.47	$99.79	$113.41	-56.84%

Similar to BIIB